2 options
Morgan Life Sciences / Ben Flaumenhaft & Constance E. Bagley.
SAGE knowledge Connect to full text Available online
View online- Format:
- Book
- Author/Creator:
- Flaumenhaft, Ben, author.
- Bagley, Constance E., author.
- Series:
- SAGE knowledge. Cases.
- SAGE Knowledge. Cases.
- SAGE knowledge. Cases
- Language:
- English
- Subjects (All):
- Morgan Life Sciences (Firm).
- Organizational change--Case studies.
- Organizational change.
- Business planning--Case studies.
- Business planning.
- Biotechnology industries--Case studies.
- Biotechnology industries.
- Genre:
- Case studies.
- Physical Description:
- 1 online resource : illustrations (black and white, and colour).
- Place of Publication:
- [London] : SAGE, 2016.
- System Details:
- text file
- Summary:
- Morgan Life Sciences was a biotechnology firm headquartered in Waltham, Massachusetts. Initially, it focused on generic and over-the-counter medications, which it manufactured and distributed to drugstores and supermarket chains. Morgan completed a successful initial public offering in 1994, but by the late 1990s, the generics market had become increasingly competitive. Morgan steadily lost ground as its larger, low-cost competitors pushed prices relentlessly downward. This study explains how CEO Wendy Shaw set about transforming the fortunes of the company.
- Notes:
- Originally Published in: Flaumenhaft, B., & Bagley, C. E. (2008). Morgan Life Sciences. 08-021. New Haven, CT: Yale School of Management, Yale University.
- No ILL or scholarly sharing allowed.
- Description based on online resource; title from home page (viewed on May 3, 2016).
- ISBN:
- 9781473973343
- OCLC:
- 1017726497
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.